Drugs / DTG
last change Nov 2019 re-read 9 days ago

DTG

Developed for
HIV infectious disease
Investigated by
Mills Clinical Research · ViiV Healthcare

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03275701 Jul 2016 → Oct 2019 HIV infectious disease Mills Clinical Research Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DTG “Open Label, Switch to Triumeq (ABC/DTG/3TC)” NCT03275701 ↗